Form D · Biotechnology
Keraplast Manufacturing
Lincoln, Q2 · CIK 0002012473
Offering snapshot reported Feb 21, 2024 · SEC filing
- Reported sold
- $1.26M Offering amount: $1.26M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1.26M Reported outside-investor minimum
- First sale
- Dec 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2024 | Initial | $1,264,782 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505714
Source: Form D, filed Feb 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Howard Herring | Director |
| Edward Shihai Lee | Director |
| Howard Stanley Moore | Director, Executive |
| Michael William Shea | Director |
| Robert Allen Smith | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Corner Of Springs Road And Gerald St.
Lincoln, Q2, 7608
Lincoln, Q2, 7608